Stocks · Health care · Pharmaceutical Preparations

SUPERNUS PHARMACEUTICALS, INC.

SUPN Clue Score33
United States Fiscal year ends December CIK 0001356576 Results filed 29 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Jack A. Khattar
13 Mar 2026
President, CEO
Sold on a plan indirect
120
$51.75
$6.21K
Jack A. Khattar
13 Mar 2026
President, CEO
Sold on a plan indirect
10,742
$51.00
$547.84K
Jack A. Khattar
13 Mar 2026
President, CEO
Sold on a plan indirect
24,138
$50.09
$1.21M

What was left out

Form 4 filings counted 66
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 12
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 2,909,472
History held since 7 May 2012